Clinical Trials

• NWCS 408: Examining Longitudinal Cytokine Profiles in HIV-TB Co-infected Participants

  Study Location: India

  Eligibility:

  Enrollment:

  Read More

• A5349: Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A

  Study Location: India

  Eligibility: Ages Eligible for Study: 12 Years and older   (Child, Adult, Senior) Genders Eligible for Study:   Both Accepts...

  Enrollment:

  Read More

• A5350: Effects of Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers

  Study Location:

  Eligibility: Participants in the study must: Have HIV infection Be on stable HIV treatment for at least the last 24 weeks Have...

  Enrollment: Closed

  Read More

• HPTN 078: Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM

  Study Location: Baltimore

  Eligibility: Ages Eligible for Study:   16 Years and older Genders Eligible for Study:   Male Accepts Healthy Volunteers:  ...

  Enrollment:

  Read More

• A5128: Consent for Use of Stored Patient Specimens for Future Testing

  Study Location: Baltimore

  Eligibility: Genders Eligible for Study:   Both Accepts Healthy Volunteers:   Yes Sampling Method:   Non-Probability Sample...

  Enrollment:

  Read More

• A5342: Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody

  Study Location: Baltimore

  Eligibility: Ages Eligible for Study:   18 Years to 65 Years Genders Eligible for Study:   Both Accepts Healthy Volunteers:  ...

  Enrollment: Closed

  Read More

• A5300/P2003: PHOENIx Feasibility Study

  Study Location: India

  Eligibility: Feasibility Study; N/A

  Enrollment:

  Read More

• A5332: Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

  Study Location: BaltimoreIndia

  Eligibility: HIV infected men and women between the ages of 40 and 75 On HIV medications for at least 6 months CD4 cell count greater...

  Enrollment:

  Read More

• A5329: Interferon –Free Therapy for Chronic Hepatitis C Virus Genotype 1 infection in persons with

  Study Location: Baltimore

  Eligibility: HIV and Hepatitis C co-infected people 18 to 70 years old HIV viral load less than 50 copies Currently on one of the...

  Enrollment:

  Read More

• HPTN 069: A Phase II Randomized, Double-Blind, Study of the Safety and Tolerability of Maraviroc

  Study Location: Baltimore

  Eligibility: HIV-uninfected at-risk MSM and at-risk women > 18 years.

  Enrollment: Closed

  Read More
•  < 1 2 3 4 5 >